Migraine with aura induced by artificial microbubbles
M Zaletel,
B Zvan,
M Koželj, K Prokšelj, T Podnar,
P Berden,
D Mishaly,
M Zaletel
Department of Neurology, University Clinical Centre Ljubljana,
Search for more papers by this authorB Zvan
Department of Neurology, University Clinical Centre Ljubljana,
Search for more papers by this authorT Podnar
Department of Pediatrics, Vrazov trg, Ljubljana, Slovenia, and
Search for more papers by this authorP Berden
Department of Radiology, University Medical Centre Ljubljana, Zaloška cesta,
Search for more papers by this authorD Mishaly
The Chaim Sheba Medical Center, Department of Pediatric Cardiovascular Surgery, Tel Hashomer, The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Izrael
Search for more papers by this authorM Zaletel,
B Zvan,
M Koželj, K Prokšelj, T Podnar,
P Berden,
D Mishaly,
M Zaletel
Department of Neurology, University Clinical Centre Ljubljana,
Search for more papers by this authorB Zvan
Department of Neurology, University Clinical Centre Ljubljana,
Search for more papers by this authorT Podnar
Department of Pediatrics, Vrazov trg, Ljubljana, Slovenia, and
Search for more papers by this authorP Berden
Department of Radiology, University Medical Centre Ljubljana, Zaloška cesta,
Search for more papers by this authorD Mishaly
The Chaim Sheba Medical Center, Department of Pediatric Cardiovascular Surgery, Tel Hashomer, The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Izrael
Search for more papers by this authorMarjan Zaletel MD PhD, University Medical Centre Ljubljana, Department of Neurology, Zaloska c. 7, SI-1525 Ljubljana, Slovenia, Europe. Tel. + 386 41 761 288, fax + 386 1 522 22 08, e-mail [email protected]
References
- 1 Schwedt TJ, Dodick DW. Patent foramen ovale and migraine–bringing closure to the subject. Headache 2006; 46: 663–71.
- 2 Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13: 102–6.
- 3 Post MC, Budts W. The relationship between migraine and right-to-left shunt: fact or fiction? Chest 2006; 130: 896–901.
- 4 Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache 2006; 46: 429–34.
- 5 Dinia L, Roccatagliata L, Bonzano L, Finocchi C, Del Sette M. Diffusion MRI during migraine with aura attack associated with diagnostic microbubbles injection in subjects with large PFO. Headache 2007; 47: 1455–6.
- 6 Tembl J, Lago A, Sevilla T, Solis P, Vilchez J. Migraine, patent foramen ovale and migraine triggers. J Headache Pain 2007; 8: 7–12.
- 7 Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci 2001; 100: 215–20.
- 8 Gorji A. Spreading depression: a review of the clinical relevance. Brain Res Rev 2001; 38: 33–60.
- 9 Olesen J, Friberg L, Olsen TS, Andersen AR, Lassen NA, Hansen PE, Karle A. Ischaemia induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993; 116: 187–202.
- 10 Kitano A, Shimomura T, Takeshima T, Takahashi K. Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. Headache 1994; 34: 515–18.
- 11 Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and metaanalysis of observational studies. BMJ 2005; 330: 63–5.
- 12 Welch KM. Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention. Headache 2005; 45 (Suppl. 1): S25–32.
- 13 Telman G, Kouperberg E, Sprecher E, Goldsher D, Yarnitsky D. Distribution of artificial cerebral microemboli in stroke patients with patent foramen ovale. Neurol Res 2005; 27: 109–11.
- 14 Gunaydin S, Soysal A, Atay T, Arpaci B. Motor and occipital cortex excitability in migraine patients. Can J Neurol Sci 2006; 33: 63–7.
- 15 Yankovsky AE, Kuritzky A. Transformation into daily migraine with aura following transcutaneous atrial septal defect closure. Headache 2003; 43: 496–8.
- 16 Muta H, Ishii M, Maeno Y, Akagi T, Kato H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002; 91: 649–52.
- 17 Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004; 90: 1315–20.
- 18 Fragoso YD. Reduction of migraine attacks during the use of warfarin. Headache 1997; 37: 667–8.
- 19 Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62: 1399–401.
